March 26, 2021
AstraZeneca pushes back vaccines-in-Italy topic
AstraZeneca has issued a statement to clarify a number of inaccurate statements relating to COVID-19 Vaccine AstraZeneca doses at the Anagni plant in Italy.
Pharmaceuticals, Biotechnology and Life Sciences
Category: Europe
March 26, 2021
Novadiscovery, Takeda in new clinical simulation collaboration
Novadiscovery has entered into a new collaboration with Takeda Pharmaceutical Company Limited (“Takeda”) aimed at incorporating clinical simulation technology on virtual patients into Takeda France’s access strategy.
March 25, 2021
AstraZeneca answers accusation to stockpiling vaccines; 13M doses for COVAX, 16M for Europe
AstraZeneca has denied accusations of stockpiling vaccines stating that the process of manufacturing vaccines is very complex and time consuming…
March 24, 2021
Boehringer Ingelheim sees positive business momentum in 2020 despite impact of COVID-19
In particular, efforts to research potential COVID-19 related therapies were accelerated, Boehringer Ingelheim spent 3.7 billion EUR on R&D, 7% more than in the previous year
March 24, 2021
Novo Nordisk weight loss drug shows good results in a 68-week trial
Novo Nordisk’a new results from the STEP phase 3a clinical trial programme showed weight loss with investigational treatment of once-weekly subcutaneous semaglutide 2.4 mg versus placebo.
March 24, 2021
Bayer’s NTRK fusion-positive tumor drug approved in Japan
Bayer has announced that the Japanese Ministry of Health, Labor and Welfare (MHLW) has granted marketing authorization for larotrectinib, under the brand name Vitrakvi, for the treatment of Neurotrophic Tyrosine Receptor Kinase (NTRK) fusion-positive advanced or recurrent solid tumors.
March 23, 2021
Promega Biotech Ibérica Earns Recognition for COVID-19 Response in Spain
La Razón, a daily newspaper based in Madrid, recently honored Promega Biotech Ibérica with a Madrid Community SME (small- and medium-sized business) Award for demonstrating adaptation and innovation to lead the pandemic recovery in Spain.
March 23, 2021
Investigational AstraZeneca vaccine prevents COVID-19
Results from a large clinical trial in the United States and South America indicate that AstraZeneca’s COVID-19 vaccine, AZD1222, is…
March 22, 2021
IONTAS Identifies Novel SARS-CoV-2 Neutralising Antibodies
Potent antibodies shown to retain binding to major COVID-19-causing “South African” variant IONTAS now seeking development partners CAMBRIDGE, England &…
March 19, 2021
UK and EU regulatory agencies confirm COVID-19 Vaccine AstraZeneca is safe and effective
Today the Medicines and Healthcare products Regulatory Agency (MHRA) and European Medicines Agency (EMA) reaffirmed the benefits of COVID-19 Vaccine AstraZeneca continue to far outweigh the risks.